Abstract:Objective To explore the effects of celecoxib on hepatic adiponectin receptors(Adipo-R1,Adipo-R2)in rats with nonalcoholic steatohepatitis(NASH).Methods Thirty Sprague-Dawley male rats were randomly divided into the normal group(n=10),the model group(n=10,fed with a high-fat diet for 12weeks)and the celecoxib group(n=10,fed the same diet as NASH group supplemented with the solution of celecoxib 80 mgo.kg-1.d-1gavage daily from the 12th week for 8 weeks).Serum and liver samples were collected until used at the 20th week.Each histological sample by HE and Masson staining was evaluated for steatosis,inflammation and fibrosis.Biochemical parameters of antioxidant enzyme activities and adiponectin,TNF-α,prostaglandin E2(PGE2)in serum and hepatic samples were estimated by automatic biochemical analyzer and enzyme linked immunosorbent assay(ELISA)kit,respectively.The mRNA and protein expressions of Adipo-R1,Adipo-R2 and COX-2 were disclosed by real-time PCR and Western blot analysis.Changes in serum and liver biochemical indicators were used one-way analysis of variance(ANOVA)(S-N-K method)and liver pathological changes were used the Wilcoxon's signed-rank test for the statistical analysis,respectively.Results Compared with the model group,histological samples in the celecoxib group showed a significant improvement in fat,inflammation and fibrosis(χ2=29.130,P<0.001.χ2= 23.330,P <0.001.χ2=14.678,P=0.002).The levels of serum and liver tissues in total anti-oxidation competence,superoxide dismutase,catalase,glutathione peroxidase and malondialdehyde in celecoxib group were significantly ameliorated compared with those in the model group [Serum: F=6.116,P=0.002(T-AOC).F=14.572,P=0.022(T-SOD).F=8.393,P=0.0003(CAT).F=9.272,P=0.0014(GSH-PX).F=18.380,P=0.002(MDA).liver tissues: F=12.416,P<0.0001(T-AOC).F=44.276,P=0.0002(T-SOD).F=28.269,P=0.0003(CAT).F=16.392 P=0.010(GSH-PX).F=5.367,P=0.0016(MDA)].Real-time PCR and Western blot revealed mRNA and protein expressions of Adipo R1,Adipo R2 were decreased(Adipo-R1mRNA,2.13 ±0.13vs.0.98±0.04,P=0.003.Adipo-R1 protein,0.72±0.07 vs.0.51±0.04,P=0.017.Adipo-R2 mRNA,1.75±0.19 vs.0.34±0.10,P=0.015.Adipo-R2 protein,0.49±0.03 vs.0.31±0.05,P=0.008)and COX-2 was increased(COX-2 mRNA,0.57±0.08 vs.2.83±0.24,P=0.005.Protein,0.45±0.04 vs.0.94±0.06,P=0.018)in the model group.After celecoxib intervention,all of those indicators exhibited markedly improved(Adipo-R1 mRNA,2.08± 0.22.Adipo-R2 mRNA,0.75 ±0.08.COX-2 mRNA,0.76 ±0.10.Adipo R1 protein,0.60 ±0.02.Adipo R2 protein,0.62 ±0.06.COX-2 protein,0.6 ±0.05,all P <0.01).Conclusions Celecoxib is effective in the treatment of experimental NASH,at least in part,through increasing the expressions of hepatic Adipo-R1 and Adipo-R2.

Protective effect of lycopene against celecoxib induced fat deposition and glycogen reduction in liver cells

Celecoxib Attenuates Hepatosteatosis by Impairing De Novo Lipogenesis Via Akt-dependent Lipogenic Pathway

Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat

Celecoxib-mediated Attenuation of Non-Alcoholic Steatohepatitis is Potentially Relevant to Redistributing the Expression of Adiponectin Receptors in Rats.

Effects of celecoxib on hepatic adiponectin receptors in rats with nonalcoholic steatohepatitis

Lycopene Alleviates Chronic Stress-Induced Liver Injury by Inhibiting Oxidative Stress-Mediated Endoplasmic Reticulum Stress Pathway Apoptosis in Rats

Role of Cytosolic Liver Fatty Acid Binding Protein in Hepatocellular Oxidative Stress: Effect of Dexamethasone and Clofibrate Treatment

Effects of Lonicera Caerulea Berry Extract on Lipopolysaccharide-Induced Toxicity in Rat Liver Cells: Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activities

Protective role of lycopene against metabolic disorders induced by chronic bisphenol A exposure in rats

Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice

Enhancement of biochemical and genomic pathways through lycopene-loaded nano-liposomes: Alleviating insulin resistance, hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: Involvement of SMO, GLI-1, and PTCH-1 genes

Lycopene Relieves AFB1-induced Liver Injury Through Enhancing Hepatic Antioxidation and Detoxification Potential with Nrf2 Activation

Lycium Barbarum Polysaccharides Protect Mice Liver from Carbon Tetrachloride-Induced Oxidative Stress and Necroinflammation.

Lycopene improves autophagy and attenuates carbon tetrachloride-induced hepatic fibrosis in rats

Blueberry and cranberry extracts mitigate CCL4-induced liver damage, suppressing liver fibrosis, inflammation and oxidative stress

Lonicera caerulea berry extract suppresses lipopolysaccharide-induced inflammation via Toll-like receptor and oxidative stress-associated mitogen-activated protein kinase signaling.

Lycopene Prevents Lipid Accumulation in Hepatocytes by Stimulating PPARα and Improving Mitochondrial Function

Ameliorative potential of synbiotic combination of Lactobacillus sp. and polyphenols against Benzo[a]pyrene-induced toxicity in Caco-2 cell line

Lycopene abolishes palmitate-mediated myocardial inflammation in female Wistar rats via modulation of lipid metabolism, NF-κB signalling pathway, and augmenting the antioxidant systems

The Effect of Lycorine on LPS-Induced COX-2 in vivo and vitro

Lycopene Attenuates Colistin-Induced Nephrotoxicity in Mice Via Activation of the Nrf2/HO-1 Pathway.